Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

4463 ARTíCULOS , VIENDO DEL 4336 AL 4350

PUBMED

Cortical inhibitory deficits in Huntington's disease are not influenced by gender.

Philpott AL, Cummins TD, Bailey NW, Churchyard A, Fitzgerald PB, Georgiou-Karistianis N.

Psychiatry Res. 2016 Nov 30;257:1-4. doi: 10.1016/j.pscychresns.2016.04.018.

0

0

0

PUBMED

Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington's Disease.

Johnson EB, Gregory S, Johnson HJ, Durr A, Leavitt BR, Roos RA, Rees G, Tabrizi SJ, Scahill RI.

Front Neurol. 2017 Oct 10;8:519. doi: 10.3389/fneur.2017.00519. eCollection 2017.

0

0

0

PUBMED

Molecular characterization of genes modifying the age at onset in Huntington's Disease in Uruguayan patients.

Vital M, Bidegain E, Raggio V, Esperon P.

Int J Neurosci. 2015 May 22:1-17. [Epub ahead of print]

0

0

0

PUBMED

Dysphagia characteristics in Huntington's disease patients: insights from the Fiberoptic Endoscopic Evaluation of Swallowing and the Swallowing Disturbances Questionnaire.

Manor Y, Oestreicher-Kedem Y, Gad A, Zitser J, Faust-Socher A, Shpunt D, Naor S, Inbar N, Kestenbaum M, Giladi N, Gurevich T.

CNS Spectr. 2018 Sep 10:1-6. doi: 10.1017/S1092852918001037. [Epub ahead of print]

0

0

0

PUBMED

Use of electroconvulsive therapy in a patient with chorea neuroacanthocytosis and prominent delusions.

Rutherford M.

J ECT. 2012 Jun;28(2):e5-6. doi: 10.1097/YCT.0b013e31823c071d.

0

0

0

PUBMED

Huntington's Disease: The Most Curable Incurable Brain Disorder?

Wild EJ.

EBioMedicine. 2016 Jun;8:3-4. doi: 10.1016/j.ebiom.2016.05.023. No abstract available.

0

0

0

PUBMED

The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.

Kay C, Collins JA, Wright GEB, Baine F, Miedzybrodzka Z, Aminkeng F, Semaka AJ, McDonald C, Davidson M, Madore SJ, Gordon ES, Gerry NP, Cornejo-Olivas M, Squitieri F, Tishkoff S, Greenberg JL, Krause

Am J Med Genet B Neuropsychiatr Genet. 2018 Feb 20. doi: 10.1002/ajmg.b.32618. [Epub ahead of print]

0

0

0

PUBMED

The hunt for better treatments for Huntington's disease.

Barker R, Mason SL.

Lancet Neurol. 2018 Dec 14. pii: S1474-4422(18)30448-4. doi: 10.1016/S1474-4422(18)30448-4. [Epub ahead of print] No abstract available.

0

0

0

PUBMED

Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?

Banaszkiewicz K, Sitek EJ, Rudzińska M, Sołtan W, Sławek J, Szczudlik A.

J Neural Transm (Vienna). 2012 Nov;119(11):1361-5. doi: 10.1007/s00702-012-0787-x.

0

0

0

PUBMED

AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease.

Billes V, Kovács T, Hotzi B, Manzéger A, Tagscherer K, Komlós M, Tarnóci A, Pádár Z, Erdős A, Bjelik A, Legradi A, Gulya K, Gulyás B, Vellai T.

J Huntingtons Dis. 2016 May 7;5(2):133-47. doi: 10.3233/JHD-150180.

0

0

0

PUBMED

A Unique Case with Oral Dyskinesia, Chorea, Ataxia, and Mild Cognitive Impairment with Caudate Atrophy and Characteristic Brain Calcifications.

Hishikawa N, Fukui Y, Sato K, Takemoto M, Yamashita T, Ohta Y, Abe K.

Intern Med. 2018 Mar 30. doi: 10.2169/internalmedicine.9454-17. [Epub ahead of print]

0

0

0

PUBMED

Substantia nigra hyperechogenicity in hypokinetic Huntington's disease patients.

Lambeck J, Niesen WD, Reinhard M, Weiller C, Dose M, Zucker B.

J Neurol. 2015 Mar;262(3):711-7. doi: 10.1007/s00415-014-7587-1. Erratum in: J Neurol. 2015 Mar;262(3):718. Matthias, Reinhard [corrected to Reinhard, Matthias]; Matthias, Dose [corrected to Dose, Matthias]; Birgit, Zucker [corrected to Zucker, Birgit].

0

0

0

PUBMED

Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease.

Rué L, López-Soop G, Gelpi E, Martínez-Vicente M, Alberch J, Pérez-Navarro E.

Neurobiol Dis. 2013 Apr;52:219-28. doi: 10.1016/j.nbd.2012.12.008.

0

0

0

PUBMED

HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation.

Jia H, Morris CD, Williams RM, Loring JF, Thomas EA.

Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):E56-64. doi: 10.1073/pnas.1415195112.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy